Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee-March 24, 2015, 3605-3606 [2015-00935]
Download as PDF
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3312–N]
Medicare Program; Meeting of the
Medicare Evidence Development and
Coverage Advisory Committee—March
24, 2015
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces that a
public meeting of the Medicare
Evidence Development & Coverage
Advisory Committee (MEDCAC)
(‘‘Committee’’) will be held on Tuesday,
March 24, 2015. The Committee
generally provides advice and
recommendations concerning the
adequacy of scientific evidence needed
to determine whether certain medical
items and services can be covered under
the Medicare statute. This meeting will
focus on selected molecular pathology
tests for the estimation of prognosis in
common cancers (such as,
adenocarcinoma of the colon and
rectum, breast cancer—invasive duct
and lobular cancers, non-small cell lung
cancers). This meeting is open to the
public in accordance with the Federal
Advisory Committee Act (5 U.S.C. App.
2, section 10(a)).
DATES: Meeting Date: The public
meeting will be held on Tuesday, March
24, 2015 from 7:30 a.m. until 4:30 p.m.,
Eastern Daylight Time (EDT).
Deadline for Submission of Written
Comments: Written comments must be
received at the address specified in the
ADDRESSES section of this notice by 5
p.m., EST, Monday, February 23, 2015.
Once submitted, all comments are final.
Deadlines for Speaker Registration
and Presentation Materials: The
deadline to register to be a speaker and
to submit PowerPoint presentation
materials and writings that will be used
in support of an oral presentation is 5:00
p.m., EST on Monday, February 23,
2015. Speakers may register by phone or
via email by contacting the person listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice.
Presentation materials must be received
at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees
Registration: Individuals may register
online at https://www.cms.gov/apps/
events/upcomingevents.aspstrOrder
By=1&type=3 or by phone by contacting
the person listed in the FOR FURTHER
INFORMATION CONTACT section of this
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:05 Jan 22, 2015
Jkt 235001
notice by 5 p.m. EDT, Tuesday, March
17, 2015.
We will be broadcasting the meeting
live via Webcast at https://www.cms.gov/
live/.
Deadline for Submitting a Request for
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to contact the Executive Secretary
as specified in the FOR FURTHER
INFORMATION CONTACT section of this
notice no later than 5:00 p.m., EDT
Friday, March 6, 2015.
ADDRESSES: Meeting Location: The
meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services, 7500 Security
Boulevard, Baltimore, MD 21244.
Submission of Presentations and
Comments: Presentation materials and
written comments that will be presented
at the meeting must be submitted via
email to MedCACpresentations@
cms.hhs.gov or by regular mail to the
contact listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice by the date specified in the DATES
section of this notice.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Coverage and
Analysis Group, S3–02–01, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410–786–0309) or via email at
Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
MEDCAC, formerly known as the
Medicare Coverage Advisory Committee
(MCAC), provides advice and
recommendations to CMS regarding
clinical issues. (For more information
on MCAC, see the December 14, 1998
Federal Register (63 FR 68780)). This
notice announces the Tuesday, March
24, 2015, public meeting of the
Committee. During this meeting, the
Committee will discuss selected
molecular pathology tests for the
estimation of prognosis in common
cancers (adenocarcinoma of the colon
and rectum, breast cancer—invasive
duct and lobular cancers, non-small cell
lung cancers). Background information
about this topic, including panel
materials, is available at https://
www.cms.gov/medicare-coveragedatabase/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&.
We will no longer be providing paper
copies of the handouts for the meeting.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
3605
Electronic copies of all the meeting
materials will be on the CMS Web site
no later than 2 business days before the
meeting. We encourage the participation
of appropriate organizations with
expertise in selected molecular
pathology tests for the estimation of
prognosis in the above mentioned
common cancers.
II. Meeting Format
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 45 minutes. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
we may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
March 2, 2015. Your comments should
focus on issues specific to the list of
topics that we have proposed to the
Committee. The list of research topics to
be discussed at the meeting will be
available on the following Web site
prior to the meeting: https://
www.cms.gov/medicare-coveragedatabase/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&.
We require that you declare at the
meeting whether you have any financial
involvement with manufacturers (or
their competitors) of any items or
services being discussed. Speakers
presenting at the MEDCAC meeting
must include a full disclosure slide as
their second slide in their presentation
for financial interests (for example, type
of financial association—consultant,
research support, advisory board, and
an indication of level, such as minor
association < $10,000 or major
association > $10,000) as well as
intellectual conflicts of interest (for
example, involvement in a federal or
nonfederal advisory committee that has
discussed the issue) that may pertain in
any way to the subject of this meeting.
If you are representing an organization,
we require that you also disclose
conflict of interest information for that
organization. If you do not have a
PowerPoint presentation, you will need
to present the full disclosure
information requested previously at the
beginning of your statement to the
Committee.
The Committee will deliberate openly
on the topics under consideration.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
E:\FR\FM\23JAN1.SGM
23JAN1
3606
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices
chairperson. The Committee will also
allow a 15-minute unscheduled open
public session for any attendee to
address issues specific to the topics
under consideration. At the conclusion
of the day, the members will vote and
the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS’ Coverage and Analysis Group is
coordinating meeting registration. While
there is no registration fee, individuals
must register to attend. You may register
online at https://www.cms.gov/apps/
events/upcomingevents.asp?
strOrderBy=1&type=3 or by phone by
contacting the person listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice by the deadline listed in the
DATES section of this notice. Please
provide your full name (as it appears on
your state-issued driver’s license),
address, organization, telephone
number(s), fax number, and email
address. You will receive a registration
confirmation with instructions for your
arrival at the CMS complex or you will
be notified that the seating capacity has
been reached.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a federal
government building; therefore, federal
security measures are applicable. We
recommend that confirmed registrants
arrive reasonably early, but no earlier
than 45 minutes prior to the start of the
meeting, to allow additional time to
clear security. Security measures
include the following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means, of all persons
entering the building. We note that all
items brought into CMS, whether
personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not
registered in advance will not be
permitted to enter the building and will
be unable to attend the meeting. The
public may not enter the building earlier
than 45 minutes prior to the convening
of the meeting. All visitors must be
escorted in areas other than the lower
and first floor levels in the Central
Building.
Authority: 5 U.S.C. App. 2, section 10(a).
Dated: January 9, 2015.
Patrick Conway,
Deputy Administrator for Innovation and
Quality and CMS Chief Medical Officer.
Centers for Medicare & Medicaid Services.
[FR Doc. 2015–00935 Filed 1–22–15; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.
OMB No.: 0970–0401.
Description: Executive Order 12862
directs Federal agencies to provide
service to the public that matches or
exceeds the best service available in the
private sector. In order to work
continuously to ensure that the
Administration for Children and
Families’ programs are effective and
meet our customers’ needs we use a
generic clearance process to collect
qualitative feedback on our service
delivery. This collection of information
is necessary to enable ACF to garner
customer and stakeholder feedback in
an efficient timely manner, in accord
with our commitment to improving
service delivery. The information
collected from our customers and
stakeholders will help ensure that users
have an effective, efficient and
satisfying experience with the programs.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or change in
operation might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between
ACF and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
This request is an extension of the
‘‘generic fast-track’’ process offered to
all government agencies by OMB in
2010. Fast-track means each request
receives approval five days after
submission, if no issues are brought to
ACF’s attention by OMB within the five
days.
Respondents: Individuals, State and
Local Governments, and Tribes.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Survey ..............................................................................................................
tkelley on DSK3SPTVN1PROD with NOTICES
Instrument
3000
1
0.5
2500
Estimated Total Annual Burden
Hours:
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
VerDate Sep<11>2014
18:05 Jan 22, 2015
Jkt 235001
identified by the title of the information
collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 80, Number 15 (Friday, January 23, 2015)]
[Notices]
[Pages 3605-3606]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00935]
[[Page 3605]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3312-N]
Medicare Program; Meeting of the Medicare Evidence Development
and Coverage Advisory Committee--March 24, 2015
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces that a public meeting of the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC)
(``Committee'') will be held on Tuesday, March 24, 2015. The Committee
generally provides advice and recommendations concerning the adequacy
of scientific evidence needed to determine whether certain medical
items and services can be covered under the Medicare statute. This
meeting will focus on selected molecular pathology tests for the
estimation of prognosis in common cancers (such as, adenocarcinoma of
the colon and rectum, breast cancer--invasive duct and lobular cancers,
non-small cell lung cancers). This meeting is open to the public in
accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2,
section 10(a)).
DATES: Meeting Date: The public meeting will be held on Tuesday, March
24, 2015 from 7:30 a.m. until 4:30 p.m., Eastern Daylight Time (EDT).
Deadline for Submission of Written Comments: Written comments must
be received at the address specified in the ADDRESSES section of this
notice by 5 p.m., EST, Monday, February 23, 2015. Once submitted, all
comments are final.
Deadlines for Speaker Registration and Presentation Materials: The
deadline to register to be a speaker and to submit PowerPoint
presentation materials and writings that will be used in support of an
oral presentation is 5:00 p.m., EST on Monday, February 23, 2015.
Speakers may register by phone or via email by contacting the person
listed in the FOR FURTHER INFORMATION CONTACT section of this notice.
Presentation materials must be received at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees Registration: Individuals may
register online at https://www.cms.gov/apps/events/upcomingevents.aspstrOrderBy=1&type=3 or by phone by contacting the
person listed in the FOR FURTHER INFORMATION CONTACT section of this
notice by 5 p.m. EDT, Tuesday, March 17, 2015.
We will be broadcasting the meeting live via Webcast at https://www.cms.gov/live/.
Deadline for Submitting a Request for Special Accommodations:
Persons attending the meeting who are hearing or visually impaired, or
have a condition that requires special assistance or accommodations,
are asked to contact the Executive Secretary as specified in the FOR
FURTHER INFORMATION CONTACT section of this notice no later than 5:00
p.m., EDT Friday, March 6, 2015.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Boulevard, Baltimore, MD 21244.
Submission of Presentations and Comments: Presentation materials
and written comments that will be presented at the meeting must be
submitted via email to MedCACpresentations@cms.hhs.gov or by regular
mail to the contact listed in the FOR FURTHER INFORMATION CONTACT
section of this notice by the date specified in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare & Medicaid Services, Center for Clinical
Standards and Quality, Coverage and Analysis Group, S3-02-01, 7500
Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone
(410-786-0309) or via email at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
MEDCAC, formerly known as the Medicare Coverage Advisory Committee
(MCAC), provides advice and recommendations to CMS regarding clinical
issues. (For more information on MCAC, see the December 14, 1998
Federal Register (63 FR 68780)). This notice announces the Tuesday,
March 24, 2015, public meeting of the Committee. During this meeting,
the Committee will discuss selected molecular pathology tests for the
estimation of prognosis in common cancers (adenocarcinoma of the colon
and rectum, breast cancer--invasive duct and lobular cancers, non-small
cell lung cancers). Background information about this topic, including
panel materials, is available at https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&. We will
no longer be providing paper copies of the handouts for the meeting.
Electronic copies of all the meeting materials will be on the CMS Web
site no later than 2 business days before the meeting. We encourage the
participation of appropriate organizations with expertise in selected
molecular pathology tests for the estimation of prognosis in the above
mentioned common cancers.
II. Meeting Format
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 45 minutes. Time
allotted for each presentation may be limited. If the number of
registrants requesting to speak is greater than can be reasonably
accommodated during the scheduled open public hearing session, we may
conduct a lottery to determine the speakers for the scheduled open
public hearing session. The contact person will notify interested
persons regarding their request to speak by March 2, 2015. Your
comments should focus on issues specific to the list of topics that we
have proposed to the Committee. The list of research topics to be
discussed at the meeting will be available on the following Web site
prior to the meeting: https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&. We require that
you declare at the meeting whether you have any financial involvement
with manufacturers (or their competitors) of any items or services
being discussed. Speakers presenting at the MEDCAC meeting must include
a full disclosure slide as their second slide in their presentation for
financial interests (for example, type of financial association--
consultant, research support, advisory board, and an indication of
level, such as minor association < $10,000 or major association >
$10,000) as well as intellectual conflicts of interest (for example,
involvement in a federal or nonfederal advisory committee that has
discussed the issue) that may pertain in any way to the subject of this
meeting. If you are representing an organization, we require that you
also disclose conflict of interest information for that organization.
If you do not have a PowerPoint presentation, you will need to present
the full disclosure information requested previously at the beginning
of your statement to the Committee.
The Committee will deliberate openly on the topics under
consideration. Interested persons may observe the deliberations, but
the Committee will not hear further comments during this time except at
the request of the
[[Page 3606]]
chairperson. The Committee will also allow a 15-minute unscheduled open
public session for any attendee to address issues specific to the
topics under consideration. At the conclusion of the day, the members
will vote and the Committee will make its recommendation(s) to CMS.
III. Registration Instructions
CMS' Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. You may register online at https://www.cms.gov/apps/events/upcomingevents.asp?strOrderBy=1&type=3 or by phone by contacting
the person listed in the FOR FURTHER INFORMATION CONTACT section of
this notice by the deadline listed in the DATES section of this notice.
Please provide your full name (as it appears on your state-issued
driver's license), address, organization, telephone number(s), fax
number, and email address. You will receive a registration confirmation
with instructions for your arrival at the CMS complex or you will be
notified that the seating capacity has been reached.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a federal government building;
therefore, federal security measures are applicable. We recommend that
confirmed registrants arrive reasonably early, but no earlier than 45
minutes prior to the start of the meeting, to allow additional time to
clear security. Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means,
of all persons entering the building. We note that all items brought
into CMS, whether personal or for the purpose of presentation or to
support a presentation, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45 minutes
prior to the convening of the meeting. All visitors must be escorted in
areas other than the lower and first floor levels in the Central
Building.
Authority: 5 U.S.C. App. 2, section 10(a).
Dated: January 9, 2015.
Patrick Conway,
Deputy Administrator for Innovation and Quality and CMS Chief Medical
Officer. Centers for Medicare & Medicaid Services.
[FR Doc. 2015-00935 Filed 1-22-15; 8:45 am]
BILLING CODE 4120-01-P